Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von JREMY 

Charles River Labs Intl diskutieren

Charles River Labs Intl

WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

198,30 €
0,53 %

22 0
22
0

Charles River Laboratories International (NYSE:CRL) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for CRL provided by MarketBeat

Evercore ISI 
0
Melden Teilen
13.01.26 Buy 2,40 %

Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for CRL provided by MarketBeat

TD Cowen 
0
Melden Teilen
22.01.26 Buy 3,19 %

Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for CRL provided by MarketBeat

TD Cowen 
0
Melden Teilen
20.02.26 Buy 39,16 %

Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat

Evercore Inc. 
0
Melden Teilen
10.04.26 Buy 32,38 %

Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for CRL provided by MarketBeat

Barclays PLC 
0
Melden Teilen
08.05.26 Buy 29,38 %

Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat

Evercore Inc. 
0
Melden Teilen
08.05.26 Buy 29,38 %
Einschätzung Buy
Rendite (%) 24,95 %
Kursziel 189,46
Veränderung
Endet am 17.06.27

Charles River Laboratories International (CRL) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $220.00 price target on the stock, up from $185.00.
Ratings data for CRL provided by MarketBeat

Morgan Stanley 
0
Melden Teilen
17.06.26

Charles River Laboratories International (CRL) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for CRL provided by MarketBeat

Citigroup Inc. 
0
Melden Teilen
08.07.26 Buy 2,22 %

Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for CRL provided by MarketBeat

Morgan Stanley 
0
Melden Teilen
09.07.26 Buy -0,85 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

JPMorgan_Chase___Co_ in F5 Networks Inc. diskutieren
F5 (FFIV) had its price target raised by JPMorgan Chase &...
15:45
Truist_Financial_Co_ in Tenet Healthcare diskutieren
Tenet Healthcare (THC) had its price target raised by Tru...
15:45
Argus in Tractor Supply Company diskutieren
Tractor Supply (TSCO) had its price target lowered by Arg...
15:30
Truist_Financial_Co_ in Discuss Huntington Bancshares Inc.
Huntington Bancshares (HBAN) had its price target raised ...
15:30
UBS_Group_AG in Becton, Dickinson & Co. diskutieren
Becton, Dickinson and Company (BDX) was given a new $190....
15:15
Roth_Mkm in Cincinnati Financial Corp. diskutieren
Cincinnati Financial (CINF) had its "buy" rating reaffirm...
15:15
Jefferies_Financial_ in Inter Parfums Inc. diskutieren
Interparfums (IPAR) had its "buy" rating reaffirmed by Je...
15:15
Royal_Bank_of_Canada in Tesla Inc diskutieren
Tesla (TSLA) had its "outperform" rating reaffirmed by Ro...
15:15
Mehr anzeigen